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PURPOSE:	  Most	  individuals	  with	  infantile	  nystagmus	  (IN)	  have	  an	  idiosyncratic	  gaze	  angle	  at	  23	  
which	  their	  nystagmus	  intensity	  is	  minimised.	  Some	  adopt	  an	  abnormal	  head	  posture	  to	  use	  24	  
this	  ‘null	  zone’,	  and	  it	  has	  therefore	  long	  been	  assumed	  that	  this	  provides	  nystagmats	  with	  25	  
improved	  visual	  acuity	  (VA).	  However,	  recent	  studies	  suggest	  that	  ‘improving’	  the	  26	  
nystagmus	  waveform	  could	  have	  little,	  if	  any,	  influence	  on	  VA;	  i.e.,	  VA	  is	  fundamentally	  27	  
limited	  in	  IN.	  Here,	  we	  examined	  the	  impact	  of	  the	  null	  zone	  on	  VA.	  28	  
METHODS:	  VA	  was	  measured	  in	  eight	  adults	  with	  IN	  using	  a	  psychophysical	  staircase	  29	  
procedure	  with	  reversals	  at	  three	  horizontal	  gaze	  angles,	  including	  the	  null	  zone.	  30	  
RESULTS:	  As	  expected,	  changes	  in	  gaze	  angle	  affected	  nystagmus	  amplitude,	  frequency,	  31	  
foveation	  duration	  and	  variability	  of	  inter-­‐cycle	  foveation	  position.	  Across	  participants,	  each	  32	  
parameter	  (except	  frequency)	  was	  significantly	  correlated	  with	  VA.	  Within	  any	  given	  33	  
individual,	  there	  was	  a	  small	  but	  significant	  improvement	  in	  VA	  (0.08	  logMAR)	  at	  the	  null	  34	  
zone	  as	  compared	  with	  the	  other	  gaze	  angles	  tested.	  Despite	  this,	  no	  change	  in	  any	  of	  the	  35	  
nystagmus	  waveform	  parameters	  was	  significantly	  associated	  with	  changes	  in	  VA	  within	  36	  
individuals.	  37	  
CONCLUSIONS:	  A	  strong	  relationship	  between	  VA	  and	  nystagmus	  characteristics	  exists	  38	  
between	  individuals	  with	  IN.	  Although	  significant,	  the	  improvement	  in	  VA	  observed	  within	  39	  
individuals	  at	  the	  null	  zone	  is	  much	  smaller	  than	  might	  be	  expected	  from	  the	  occasionally	  40	  
large	  variations	  in	  intensity	  and	  foveation	  dynamics	  (and	  anecdotal	  patient	  reports	  of	  41	  
improved	  vision),	  suggesting	  that	  improvement	  of	  other	  aspects	  of	  visual	  performance	  may	  42	  




Infantile	  nystagmus	  (IN)	  is	  a	  regular,	  repetitive,	  predominantly	  horizontal	  involuntary	  45	  
movement	  of	  the	  eyes.	  It	  usually	  develops	  within	  the	  first	  six	  months	  of	  life,	  resulting	  in	  46	  
ocular	  oscillations	  that	  are	  constantly	  present	  and	  persist	  throughout	  life.	  Even	  in	  the	  47	  
absence	  of	  any	  other	  detectable	  pathology,	  cases	  of	  IN	  are	  typically	  associated	  with	  a	  48	  
moderate	  reduction	  in	  visual	  acuity	  (VA).1	  49	  
For	  reasons	  that	  are	  not	  fully	  understood,	  the	  orientation	  of	  the	  eye	  in	  the	  orbit	  (i.e.	  gaze	  50	  
angle)	  affects	  one	  or	  more	  of	  the	  characteristics	  of	  the	  involuntary	  oscillations,	  including	  the	  51	  
amplitude,	  frequency	  and/or	  waveform	  type.2,3	  This	  results	  in	  a	  direction	  of	  gaze	  in	  which	  52	  
the	  intensity	  of	  the	  oscillations	  is	  at	  a	  minimum,	  termed	  the	  null	  position	  or	  null	  zone.4	  53	  
Individuals	  with	  IN	  whose	  null	  zone	  is	  not	  straight	  ahead	  will	  often	  adopt	  an	  abnormal	  head	  54	  
posture	  in	  order	  to	  place	  the	  eyes	  at	  this	  gaze	  angle,1	  thus	  dampening	  the	  nystagmus	  and	  55	  
often	  increasing	  the	  duration	  of	  foveations	  (the	  period	  in	  each	  cycle	  of	  the	  waveform	  during	  56	  
which	  the	  eyes	  move	  most	  slowly).	  This	  null	  zone	  may	  be	  used	  preferentially	  in	  many	  57	  
situations.1	  One	  might	  therefore	  presume	  that	  utilising	  the	  null	  zone	  would	  cause	  VA	  to	  58	  
increase.	  Indeed,	  when	  plotted	  between	  individuals	  with	  IN,	  foveation	  duration	  is	  positively	  59	  
associated	  with	  VA.5	  Moreover,	  a	  study	  by	  Costa	  et	  al.	  demonstrated	  that	  the	  clinical	  VA	  of	  60	  
children	  with	  IN	  (as	  measured	  using	  the	  Lea	  Grating	  Acuity	  Test)	  was	  significantly	  improved	  61	  
by	  using	  the	  null	  zone6.	  A	  recent	  study	  by	  Proudlock	  et	  al.7	  has	  found	  similar	  results,	  62	  
reporting	  that	  changes	  in	  gaze	  angle	  (through	  use	  of	  the	  nystagmus	  null	  zone)	  cause	  63	  
significant	  changes	  in	  clinically-­‐measured	  VA.	  64	  
In	  contrast	  to	  these	  findings,	  recent	  work	  has	  suggested	  that	  VA	  may	  be	  fundamentally	  65	  
limited	  in	  adults	  with	  IN,8	  meaning	  that	  treatments	  aiming	  to	  reduce	  (or	  even	  eliminate)	  66	  
4	  
	  
retinal	  image	  motion	  associated	  with	  the	  eye	  movements	  are	  unlikely	  to	  yield	  large	  67	  
improvements	  to	  VA.	  This	  is	  at	  direct	  odds	  with	  the	  conventional	  view	  that	  reducing	  68	  
nystagmus	  intensity	  and/or	  increasing	  foveation	  duration	  will	  lead	  to	  improved	  VA.	  It	  should	  69	  
be	  remembered	  that,	  due	  to	  the	  retinal	  image	  motion	  resulting	  from	  the	  incessant	  eye	  70	  
movements,	  there	  is	  likely	  to	  be	  a	  dynamic	  component	  to	  the	  visual	  input	  in	  the	  presence	  of	  71	  
nystagmus,	  unlike	  most	  visual	  pathologies,	  which	  are	  ‘static’.	  As	  a	  result,	  VA	  (an	  exclusively	  72	  
spatial	  measure	  of	  the	  resolving	  power	  of	  the	  visual	  system)	  cannot	  provide	  a	  complete	  73	  
account	  of	  the	  visual	  experience	  in	  those	  with	  IN.	  Temporal	  factors,	  such	  as	  cycle-­‐to-­‐cycle	  74	  
variability	  in	  foveation	  position	  (which	  is	  known	  to	  be	  correlated	  with	  clinical	  VA	  between	  75	  
individuals9,10),	  are	  also	  likely	  to	  have	  an	  impact	  on	  visual	  performance.	  In	  the	  clinic,	  the	  76	  
time	  taken	  to	  make	  a	  measurement	  of	  VA	  is	  not	  standardised.	  Factors	  specific	  to	  IN	  may	  77	  
affect	  how	  long	  it	  takes	  to	  achieve	  a	  VA	  threshold.	  This	  may	  explain	  why	  some	  clinical	  78	  
studies	  report	  a	  link	  between	  nystagmus	  characteristics	  and	  VA,	  whereas	  others	  do	  not.	  In	  79	  
studies	  that	  have	  measured	  VA	  using	  a	  psychophysical	  protocol,	  such	  as	  a	  forced	  choice	  80	  
staircase	  in	  which	  the	  participants	  have	  unlimited	  time	  to	  achieve	  their	  threshold	  resolution,	  81	  
modifications	  to	  the	  nystagmus	  waveform	  have	  repeatedly	  failed	  to	  elicit	  significant	  changes	  82	  
in	  VA.11–13	  On	  the	  other	  hand,	  therapeutic	  studies	  that	  measure	  VA	  using	  clinical	  letter	  83	  
charts	  frequently	  report	  changes	  in	  acuity.14,15	  84	  
Between	   individuals,	   VA	   is	   known	   to	   correlate	   with	   characteristics	   of	   the	   nystagmus	  85	  
waveform,	  such	  as	  foveation	  duration	  and	  accuracy.5,16–18	  Furthermore,	  several	  studies	  have	  86	  
investigated,	   in	   normally-­‐sighted	   individuals,	   the	   relationship	   between	   VA	   and	   foveation	  87	  
duration	  in	  simulated	  nystagmus	  waveforms	  (i.e.,	  the	  test	  stimulus	  is	  moved	  in	  such	  a	  way	  88	  
as	  to	  mimic	  nystagmus).19–22	  The	  data	  from	  each	  of	  these	  studies	  are	  presented	  in	  Figure	  1,	  89	  
5	  
	  
and	  clearly	  show	  an	  exponential	  relationship	  between	  simulated	  foveation	  duration	  and	  VA	  90	  
across	  individuals,	  i.e.	  VA	  improves	  with	  foveation	  duration.	  91	  
	  92	  
Figure	  1:	  The	  relationship	  between	  VA	  and	  foveation	  duration	  in	  simulated	  nystagmus	  in	  normally-­‐sighted	  individuals:	  93	  
results	  from	  four	  studies	  (reproduced	  with	  permission	  from	  Chung	  and	  Bedell	  [1996])20.	  94	  
In	  the	  present	  study,	  we	  aimed	  to	  determine	  the	  extent	  to	  which	  use	  of	  the	  null	  zone	  (as	  95	  
opposed	  to	  other	  gaze	  angles)	  affects	  VA	  in	  adults	  with	  IN,	  using	  a	  staircase	  protocol.	  96	  
Although	  lengthy	  in	  duration,	  these	  psychophysical	  techniques	  provide	  a	  more	  accurate	  97	  
visual	  resolution	  threshold	  than	  standard	  clinical	  testing,	  due	  to	  repeated	  measurement	  and	  98	  
the	  explicit	  lack	  of	  time	  constraints.	  In	  order	  to	  achieve	  this,	  we	  displayed	  visual	  targets	  at	  99	  
three	  horizontal	  gaze	  angles	  (null	  zone	  and	  two	  positions	  away	  from	  the	  null,	  including	  100	  
straight-­‐ahead)	  to	  provoke	  changes	  in	  the	  participants’	  eye	  movements,	  and	  measured	  the	  101	  
threshold	  VA	  at	  each	  position	  while	  simultaneously	  recording	  eye	  movements.	  102	  
Methods	  103	  
Eight	  individuals	  with	  idiopathic	  IN	  participated	  in	  the	  study	  (three	  female;	  20-­‐50	  years	  104	  
[mean	  age	  33]).	  The	  diagnosis	  of	  IN	  as	  reported	  by	  the	  participant	  or	  their	  ophthalmologist	  105	  
was	  investigated	  by	  an	  optometrist	  using	  high-­‐speed	  eye	  movement	  recording,	  106	  
6	  
	  
ophthalmoscopy,	  colour	  vision	  testing,	  slit-­‐lamp	  examination	  and	  a	  detailed	  family	  history.	  107	  
No	  participants	  reported	  being	  under	  medical	  treatment	  or	  having	  undergone	  previous	  108	  
surgery	  for	  nystagmus.	  Clinical	  VA	  was	  measured	  using	  a	  self-­‐illuminated	  Bailey-­‐Lovie	  chart;	  109	  
participants	  were	  given	  as	  long	  as	  they	  wished	  to	  view	  the	  chart,	  and	  encouraged	  to	  110	  
continue	  reading	  until	  at	  least	  four	  letters	  on	  a	  line	  were	  incorrectly	  identified.	  Participants	  111	  
with	  any	  comorbid	  visual	  pathology	  besides	  nystagmus	  were	  excluded	  (one	  participant	  from	  112	  
an	  original	  total	  of	  nine	  was	  excluded	  due	  to	  previous	  retinal	  detachment).	  The	  investigation	  113	  
was	  carried	  out	  in	  accordance	  with	  the	  Declaration	  of	  Helsinki;	  informed	  consent	  was	  114	  
obtained	  from	  the	  participants	  after	  explanation	  of	  the	  nature	  and	  possible	  consequences	  of	  115	  
the	  study.	  The	  Cardiff	  School	  of	  Optometry	  and	  Vision	  Sciences	  Research	  Ethics	  Audit	  116	  
Committee	  granted	  approval	  for	  this	  study.	  117	  
Participants	  were	  fitted	  with	  a	  head-­‐mounted	  1000	  Hz	  eye	  tracker	  (IRIS;	  Skalar	  Medical	  BV,	  118	  
Delft,	  The	  Netherlands)	  and	  seated	  at	  a	  table	  with	  a	  chin/headrest.	  The	  head	  was	  119	  
comfortably	  restrained	  with	  foam	  inserts	  placed	  beside	  the	  temples.	  A	  computer-­‐controlled	  120	  
rotational	  mirror	  system	  was	  used	  to	  calibrate	  the	  eye	  tracker.	  The	  experimental	  equipment	  121	  
and	  calibration	  method	  have	  been	  described	  previously.23	  Following	  calibration,	  the	  foam	  122	  
inserts	  were	  removed,	  and	  the	  null	  position	  (rounded	  to	  the	  nearest	  5°)	  for	  each	  participant	  123	  
was	  determined	  by	  asking	  participants	  to	  view	  a	  Landolt	  C	  target	  presented	  in	  the	  centre	  of	  124	  
a	  17ʺ″	  monitor	  at	  an	  optical	  distance	  of	  7	  m,	  using	  the	  head	  posture	  with	  which	  they	  could	  125	  
most	  easily	  view	  the	  target.	  This	  gave	  a	  reading	  from	  the	  IRIS	  system	  of	  orbital	  eye	  position,	  126	  
indicating	  the	  amount	  of	  head	  turn	  required	  to	  view	  the	  target	  most	  comfortably.	  127	  
All	  participants	  were	  made	  familiar	  with	  the	  psychophysical	  staircase	  procedure	  before	  128	  
recording	  began.	  The	  foam	  inserts	  were	  returned	  to	  the	  headrest	  to	  stabilise	  the	  head,	  and	  129	  
7	  
	  
participants	  were	  asked	  to	  locate	  the	  gap	  in	  a	  single	  Landolt	  C,	  using	  a	  two-­‐alternative	  130	  
forced	  choice	  paradigm	  (gap	  left	  or	  gap	  right).	  The	  starting	  size	  optotype	  was	  0.40	  logMAR	  131	  
above	  each	  participant’s	  best	  clinical	  VA.	  The	  presentation	  of	  subsequent	  Landolt	  C	  targets	  132	  
followed	  a	  staircase	  procedure	  using	  a	  fixed	  step	  size	  of	  0.075	  logMAR,	  and	  a	  three-­‐up/one-­‐133	  
down	  criterion.	  The	  staircase	  terminated	  after	  the	  criteria	  of	  80	  presentations	  and	  eight	  134	  
reversals	  had	  been	  satisfied.	  VA	  was	  estimated	  as	  the	  mean	  of	  the	  final	  six	  reversals.24	  135	  
Participants	  performed	  the	  task	  at	  three	  gaze	  positions:	  their	  null	  position,	  primary	  gaze	  and	  136	  
one	  other	  eccentric	  gaze	  position,	  chosen	  to	  represent	  a	  wide	  range	  of	  viewing	  angles.	  In	  137	  
the	  one	  participant	  whose	  null	  position	  coincided	  with	  straight-­‐ahead,	  two	  eccentric	  gaze	  138	  
positions	  were	  used.	  Eye	  movements	  were	  recorded	  throughout.	  Gaze	  angles	  were	  139	  
achieved	  by	  using	  the	  computer-­‐controlled	  rotational	  mirror	  system	  to	  present	  the	  stimulus	  140	  





Figure	  2:	  A)	  Schematic	  of	  laboratory	  layout,	  showing	  relative	  positions	  of	  mirror	  system	  and	  display.	  B)	  Photograph	  142	  
showing	  participant	  setup.	  143	  
8	  
	  
Regression	  analyses	  of	  the	  resulting	  dataset	  were	  performed	  using	  SPSS	  for	  Windows.25	  The	  144	  
changes	  to	  waveform	  characteristics	  (amplitude,	  frequency,	  foveation	  duration	  and	  145	  
variability	  of	  foveation	  position)	  elicited	  by	  varying	  gaze	  angle	  were	  compared	  to	  the	  change	  146	  
in	  VA	  obtained	  both	  across	  and	  within-­‐participants.	  147	  
Results	  148	  
Clinical	  details	  for	  each	  of	  the	  participants	  are	  presented	  in	  Table	  1.	  149	  












































































10°	  right	   No	   JREF	  




5°	  left	   No	   PFS	  




15°	  right	   No	   DJL	  /	  DJR	  /	  PFS	  




15°	  left	   Yes	   P	  /	  PC	  /	  T	  /	  JL	  




5°	  left	   No	   JEF	  




10°	  right	   Yes	   JL	  




Primary	   No	   JEF	  /	  PC	  




10°	  left	   No	   JEF	  
DJ(L),	   dual	   jerk	   (left);	   ET,	   esotropia;	   J(R)(EF),	   jerk	   (right)	   (with	  extended	   foveation);	   L,	   left;	  Ortho,	  orthotropia;	   P,	   pure	  151	  
pendular;	  PC,	  pseudocycloid;	  PFS,	  pendular	  with	  foveating	  saccades;	  R,	  right;	  T,	  triangular;	  XT,	  exotropia	  152	  
9	  
	  
Table	  2	  shows	  the	  experimental	  data	  (VA	  and	  eye	  movement	  characteristics)	  at	  each	  of	  the	  153	  
three	   gaze	   angles	   for	   each	   participant.	   Foveation	   duration	   indicates	   the	   length	   of	   time	  154	  
participants	  spend	  with	  low-­‐velocity	  eye	  movements	  during	  each	  nystagmus	  cycle,	  whereas	  155	  
standard	   deviation	   of	   foveation	   position	   can	   be	   considered	   as	   a	   measure	   of	   foveation	  156	  
accuracy,	  i.e.	  the	  cycle-­‐to-­‐cycle	  repeatability	  of	  foveation	  position.	  Foveations	  were	  defined	  157	  
as	   periods	   lasting	   longer	   than	  5	  ms	  during	  which	   eye	   velocity	  was	   <	  4°/s	   and	  eye	  position	  158	  
was	  within	   ±2°	   of	   the	   stimulus,	   parameters	  which	   have	   been	   used	   in	   previous	   studies	   by	  159	  
others,	  e.g.	  10,26.	  	  160	  
10	  
	  














































of	  position	  (°)	  
P1	  
+10	  (Null)	   0.056	   2.22	   4.50	   9.99	   62.29	   0.697	  
0	   0.068	   2.68	   4.33	   11.61	   46.49	   0.371	  
-­‐10	   0.081	   2.67	   5.55	   14.24	   37.30	   0.403	  
P2	  
-­‐5	  (Null)	   0.219	   1.78	   3.50	   6.23	   39.37	   0.543	  
0	   0.406	   2.37	   3.50	   8.30	   22.34	   0.651	  
+15	   0.431	   7.08	   4.67	   33.04	   2.25	   0.449	  
P3	  
+15	  (Null)	   0.306	   0.96	   5.83	   5.60	   19.18	   0.282	  
0	   0.306	   5.67	   3.50	   19.85	   21.29	   0.727	  
-­‐15	   0.331	   9.59	   3.67	   35.16	   10.08	   1.19	  
P4	  
-­‐15	  (Null)	   0.094	   1.85	   7.00	   12.95	   5.60	   0.439	  
0	   0.181	   2.64	   4.83	   12.76	   1.86	   0.524	  
+15	   0.231	   5.86	   5.83	   34.18	   10.03	   1.051	  
P5	  
-­‐5	  (Null)	   0.001	   2.11	   4.33	   9.14	   93.35	   0.216	  
0	   0.080	   2.12	   4.50	   9.54	   81.62	   0.259	  
+10	   0.068	   3.06	   4.33	   13.25	   93.72	   0.313	  
P6	  
+10	  (Null)	   0.437	   3.11	   4.67	   14.51	   29.94	   0.279	  
0	   0.462	   3.83	   4.83	   18.51	   4.24	   0.523	  
-­‐10	   0.524	   10.14	   4.33	   43.94	   2.13	   1.343	  
P7	  
0	  (Null)	   0.206	   2.60	   6.17	   16.03	   25.12	   0.665	  
-­‐5	   0.231	   4.38	   6.00	   26.28	   12.22	   0.746	  
+5	   0.319	   4.43	   5.50	   24.37	   19.64	   0.796	  
P8	  
-­‐10	  (Null)	   0.056	   2.24	   4.17	   9.33	   77.34	   0.310	  
0	   0.069	   3.02	   4.33	   13.09	   51.50	   0.326	  
+10	   0.044	   3.33	   4.50	   14.99	   66.16	   0.296	  
To	  illustrate	  the	  effects	  of	  different	  gaze	  angles	  on	  the	  nystagmus	  waveform,	  Figure	  3	  shows	  162	  
eye	  movement	  recordings	  at	  three	  gaze	  angles	  for	  three	  participants	  (P1,	  P3	  and	  P4),	  163	  
representing	  a	  range	  of	  waveforms	  (see	  Table	  1).	  The	  upper	  plot	  in	  each	  figure	  shows	  the	  164	  
nystagmus	  waveform	  in	  the	  participant’s	  null	  zone.	  In	  each	  case,	  nystagmus	  intensity	  165	  
reduces	  considerably	  in	  the	  null	  zone.	  166	  
11	  
	  
P1	   P3	   P4	  
10°	  right	  (null)	   15°	  right	  (null)	   15°	  left	  (null)	  
	   	   	  
Primary	  position	   Primary	  position	   Primary	  position	  
	   	   	  
10°	  left	   15°	  left	   15°	  right	  
	   	   	  
Figure	  3:	  Eye	  position	  recordings	  from	  three	  participants	  at	  varying	  gaze	  angles.	  167	  
The	  relationships	  between	  VA	  and	  the	  properties	  listed	  in	  Table	  2	  (except	  intensity,	  which	  is	  168	  
calculated	  as	  amplitude	  ×	  frequency)	  are	  depicted	  in	  Figure	  4.	  Each	  participant	  is	  169	  
represented	  by	  a	  different	  coloured	  symbol.	  170	  
	   








	   	   	   	   	   	   




	   	   	   







	   	   	   	   




	   	   	   	   	   




	   	   	   	   	   









	   	   	   	   
	   





A	   B	  
	   	  
C	   D	  
	   	  
Figure	   4:	   The	   relationship	   between	   VA	   and	   nystagmus	   amplitude	   (A),	   frequency	   (B),	   standard	   deviation	   of	   foveation	  171	  
position	  (C)	  and	  foveation	  duration	  (D)	  for	  all	  participants.	  Significant	  regression	  lines	  are	  shown.	  172	  
Across-­‐‑participant	  analysis	  173	  
Grouping	  data	  from	  all	  participants,	  amplitude	  exhibited	  a	  significant	  linear	  relationship	  with	  174	  
VA	  (R2	  =	  0.33,	  F1,22	  =	  10.82,	  p	  =	  0.003).	  Approximately	  33%	  of	  the	  variance	  in	  VA	  can	  be	  175	  
13	  
	  
accounted	  for	  by	  nystagmus	  amplitude.	  No	  significant	  correlation	  (linear	  or	  exponential)	  176	  
between	  VA	  and	  nystagmus	  frequency	  was	  evident	  in	  this	  group	  of	  participants.	  177	  
Again,	  grouping	  data	  from	  all	  participants,	  standard	  deviation	  of	  foveation	  position	  showed	  178	  
a	  significant	  linear	  relationship	  with	  VA	  (R2	  =	  0.27,	  F1,22	  =	  8.24,	  p	  =	  0.009;	  Figure	  4.C).	  The	  179	  
relationship	  between	  foveation	  duration	  and	  VA	  (Figure	  4.D)	  can	  be	  described	  by	  an	  180	  
exponential	  function	  with	  the	  following	  equation:	  181	  
𝑦	   = 	  0.4406𝑒)*.*++,-	  182	  
The	  time	  constant	  of	  this	  function	  is	  30	  ms,	  which	  is	  within	  the	  range	  of	  time	  constants	  183	  
previously	  reported	  by	  Chung	  and	  Bedell	  and	  others	  in	  studies	  in	  which	  normally-­‐sighted	  184	  
individuals	  were	  exposed	  to	  stimuli	  with	  motion	  simulating	  nystagmus	  waveforms19–22	  (see	  185	  
Figure	  1).	  Thus,	  95%	  of	  the	  total	  VA	  change	  occurred	  after	  three	  times	  the	  exponential	  time	  186	  
constant.	  Data	  across	  participants	  in	  our	  study	  indicate	  that	  maximal	  VA	  should	  be	  achieved	  187	  
with	  foveation	  durations	  of	  90	  ms	  or	  longer.	  188	  
Conducting	  a	  regression	  ANOVA	  revealed	  a	  significant	  relationship	  between	  foveation	  189	  
duration	  and	  VA	  across	  individuals	  (R2	  =	  0.58,	  F1,22	  =	  30.72,	  p	  <	  0.0001).	  Indeed,	  nearly	  60%	  190	  
of	  the	  variation	  in	  VA	  can	  be	  accounted	  for	  by	  foveation	  duration.	  191	  
Within-­‐‑participant	  analysis	  192	  
In	  order	  to	  determine	  whether	  there	  was	  a	  within-­‐participant	  effect	  of	  gaze	  angle	  on	  VA,	  the	  193	  
change	  in	  VA	  was	  plotted	  against	  the	  change	  in	  each	  parameter	  of	  the	  nystagmus	  waveform	  194	  
at	  and	  furthest	  away	  from	  the	  null	  zone.	  These	  are	  shown	  in	  Figure	  5.	  195	  
14	  
	  
A	   B	  
	   	  
C	   D	  
	   	  
Figure	  5:	  The	  change	  in	  VA	  and	  nystagmus	  amplitude	  (A),	  frequency	  (B),	  standard	  deviation	  of	  foveation	  position	  (C)	  and	  196	  
foveation	  duration	  (D)	  within	  individual	  participants,	  in	  and	  out	  of	  the	  preferred	  null	  zone	  197	  
Using	   a	   linear	  mixed	  model	   analysis,	   none	   of	   the	   five	   nystagmus	   parameters	   (amplitude,	  198	  
frequency,	   intensity,	   foveation	   duration	   or	   foveation	   position	   variability)	   showed	   a	  199	  
significant	  relationship	  with	  VA	  in	  the	  eight	  participants.	  Nonetheless,	  paired	  samples	  t-­‐tests	  200	  
examining	  VA	  in	  the	  null	  zone	  and	  at	  the	  two	  other	  recorded	  gaze	  angles,	  i.e.	  away	  from	  null	  201	  
15	  
	  
and	   then	   farther	   from	   the	   null	   zone,	   showed	   statistically	   significant	   improvements	   in	   VA	  202	  
(0.05	  logMAR:	  p	  =	  0.046	  and	  0.08	  logMAR:	  p	  =	  0.015,	  respectively).	  203	  
Discussion	  204	  
For	   many	   years,	   potential	   therapeutic	   interventions	   for	   IN	   have	   been	   based	   on	   the	  205	  
assumption	   that	   reducing	   nystagmus	   should	   improve	   VA	   (such	   as	   biofeedback,	   surgery,	  206	  
drugs,	  etc.).	  The	  implicit	  assumption	  has	  been	  that	  the	  self-­‐generated	  image	  motion	  caused	  207	  
by	   nystagmus	   is	   an	   important	   contributor	   to	   poor	   VA.	   This	   is	   especially	   the	   case	   for	   the	  208	  
‘pure’	   idiopath	   in	  which	  there	   is	  assumed	  to	  be	  no	  underlying	  sensory	  defect.	  Contrary	   to	  209	  
this	  intuition,	  this	  study	  has	  shown	  that	  changes	  in	  nystagmus	  intensity	  induced	  by	  changes	  210	  
in	  gaze	  direction	  are	  associated	  with	  only	  very	  small	  changes	   in	  VA	  (mean	  =	  0.08	  logMAR).	  211	  
Nevertheless,	  these	  changes	  are	  significant.	  212	  
Our	  study	  is	  based	  on	  participants’	  own	  changes	  in	  nystagmus	  parameters	  with	  gaze	  angle;	  213	  
that	   is,	  each	  participant	   is	   their	  own	  control.	  Other	  studies	   that	  are	  also	  based	  on	  within-­‐214	  
participant	  comparisons	  have	  reported	  similarly	  small	  effects	  of	  nystagmus	  intensity	  on	  VA.	  215	  
For	  example,	  studies	  on	  biofeedback	  have	  reported	  changes	  in	  nystagmus	  intensity,	  but	  only	  216	  
limited	   improvements	   in	   VA.27,28	   Inducing	   stress	   increases	   nystagmus	   intensity,	   but	   again	  217	  
has	  minimal	  effect	  on	  VA.11,12	  McLean	  et	  al.14	  showed	  that	  memantine	  and	  gabapentin	  can	  218	  
substantially	  reduce	  nystagmus	  intensity,	  but	  produce	  only	  small	  improvements	  in	  VA:	  0.15	  219	  
(±0.18),	   0.09	   (±0.05),	   and	   0.04	   (±0.03)	  logMAR	   for	   the	   idiopathic	   group	   and	   0.05	   (±0.04),	  220	  
0.04	   (±0.07),	   and	   -­‐0.03	   (±0.05)	  logMAR	   for	   the	   sensory	   defect	   group	   on	   memantine,	  221	  
gabapentin	   and	   placebo	   treatment,	   respectively.	  McLean	   et	   al.29	   recently	   expanded	   their	  222	  
study	  to	  a	  crossover	  design,	  and	  found	  no	  significant	  change	  in	  VA,	  despite	  large	  significant	  223	  
changes	  to	  nystagmus	  characteristics.	  Dunn	  et	  al.8	  argued	  that	  if	  nystagmus-­‐induced	  motion	  224	  
16	  
	  
blur	   contributed	   to	   poor	   VA	   in	   adults,	   then	   VA	   should	   improve	   if	   retinal	   smear	   were	  225	  
eliminated.	   By	   using	   very	   brief	   stimulus	   exposure	   times	   (<	  1	  ms),	   they	   found	   no	   such	  226	  
improvement	  relative	  to	  control	  participants.	  They	  concluded	  that	  the	  lack	  of	  improvement	  227	  
in	   VA	   in	   idiopaths	   may	   be	   due	   to	   an	   unknown	   underlying	   sensory	   defect	   or	   meridional	  228	  
amblyopia.	  229	  
In	   stark	   contrast,	   many	   studies	   have	   shown	   a	   strong	   relationship	   between	   VA	   and	  230	  
nystagmus	   parameters	   when	   compared	   between	   participants.5,16–22	   Indeed,	   our	   study	  231	  
highlights	  this	  difference,	  as	  seen	  by	  comparing	  the	  between-­‐participant	  effects	  in	  Figure	  4	  232	  
to	   the	   within-­‐participant	   effects	   in	   Figure	   5.	   Clearly,	   there	   is	   a	   much	   wider	   range	   of	  233	  
nystagmus	  parameters	  across	  individuals	  than	  can	  be	  induced	  within	  any	  of	  the	  individuals	  234	  
in	   this	   study.	   Thus,	  one	  possibility	   is	   that	   there	   is	   an	  underlying	   relationship	  between	   the	  235	  
nystagmus	  waveform	  and	  VA	   (as	   seen	   in	  Figure	  4	   [a,	   c	  and	  d]),	  but	   that	   there	   is	  a	   limited	  236	  
range	  of	  nystagmus	  parameters	  available	  to	  any	  individual.	  However,	  we	  are	  not	  convinced	  237	  
that	   this	   is	   the	   case,	   as	   individual	   changes	   do	   not	   follow	   the	   aggregate	   curve	   closely.	  238	  
Nevertheless,	   given	   the	   large	   variability	   in	   the	   relationship	   between	   VA	   and	   foveation	  239	  
duration,	   we	   cannot	   rule	   out	   this	   possibility.	   A	   second	   possibility	   is	   that	   the	   waveform	  240	  
adapts	   to	   the	   underlying	   VA:	   those	   with	   poorer	   VA	   develop	   nystagmus	   with	   shorter	  241	  
foveation	   periods,	   and	   the	   between-­‐participant	   effect	   is	   the	   manifestation	   of	   this	  242	  
adaptation	  across	  participants.	  Individuals,	  on	  the	  other	  hand,	  show	  little	  or	  no	  relationship	  243	  
with	   foveation	   duration,	   as	   their	   VA	   is	   more-­‐or-­‐less	   fixed.	   Since	   the	   participants	   in	   the	  244	  
present	  study	  were	  all	  adults	   (mean	  age	  33	  years),	  we	  cannot	  rule	  out	   the	  possibility	   that	  245	  
adoption	  of	  the	  nystagmus	  null	  zone	  might	  have	  a	  greater	  impact	  on	  VA	  in	  infancy	  than	  in	  246	  
adulthood,	  and	  that	  early	  treatment	  of	  nystagmus	  might	  have	  greater	  long-­‐term	  benefits	  to	  247	  
17	  
	  
VA.	   Indeed,	   Felius,	   Stager	   and	   Jost30	   have	   demonstrated	   that	   the	   benefits	   to	   VA	   of	   four-­‐248	  
muscle	  surgery	  are	  greater	  during	  the	  critical	  period	  of	  visual	  development.	  249	  
There	  have	  been	  attempts	  to	  relate	  VA	  to	  the	  nystagmus	  waveform,	  such	  as	  the	  eXpanded	  250	  
Nystagmus	   Acuity	   Function	   (NAFX)	   and	   many	   others.10,16,17,31,32	   These	   are	   based	   on	   the	  251	  
exponential	  relationship	  between	  VA	  and	  foveation	  duration	  (Figure	  1).	  The	  idea	  is	  that	  one	  252	  
can	  predict	  VA	  based	  purely	  on	  the	  waveform,	  rather	  than	  measuring	  VA.17	  However,	  these	  253	  
indices	  are	  based	  on	  between-­‐participant	  data,	  and	  are	  not	  based	  on	  how	  an	  individual’s	  VA	  254	  
changes	  with	  waveform.33	  Thus,	  an	   individual’s	  NAFX	  score	  places	  the	   individual’s	  average	  255	  
VA	  along	  a	  scale	  relative	  to	  other	  individuals’	  average	  VA,	  based	  on	  the	  average	  duration	  of	  256	  
foveation	  periods.	  As	  we	  have	  seen,	  within	  an	  individual,	  the	  relationship	  between	  VA	  and	  257	  
foveation	   periods	   is	   very	   weak,	   and	   does	   not	   follow	   the	   exponential	   relationship	   seen	  258	  
between	   participants.	   Thus,	   it	   is	   not	   possible	   to	   predict	   changes	   in	   VA	   for	   a	   specific	  259	  
individual	  based	  on	  changes	  in	  mean	  foveation	  duration.	  For	  these	  reasons,	  the	  use	  of	  these	  260	  
various	   indices	   is	   not	   only	   inappropriate,	   but	   is	   also	  misleading	   and	   circular.	   It	   would	   be	  261	  
interesting	   to	   examine	   however,	   in	   a	   larger	   cohort	   of	   participants,	   whether	   certain	  262	  
waveforms	  might	  be	  more	  susceptible	   to	  gaze	  angle	   induced	  changes	   in	  psychophysically-­‐263	  
measured	  VA.	  264	  
Dickinson	  has	  previously	  demonstrated	  that	  the	  repeatable	  changes	  in	  nystagmus	  intensity	  265	  
elicited	  by	  convergence	  do	  not	  cause	  VA,	  or	  any	  aspect	  of	  contrast	  sensitivity	   function,	   to	  266	  
improve.34	  These	  data	  raise	  the	  intriguing	  question	  of	  why	  participants	  choose	  to	  use	  their	  267	  
null	   zone,	   even	   to	   the	   extent	   of	   adopting	   head	   postures.	   As	   reported	   here,	   although	  268	  
statistically	  significant,	   the	  spatial	   resolution	  benefit	   (on	  average)	  of	  aligning	  the	  null	   zone	  269	  
with	  the	  stimulus	  is	  small;	  equivalent	  to	  less	  than	  a	  line	  on	  a	  standard	  Bailey-­‐Lovie	  chart.	  Are	  270	  
18	  
	  
these	  very	  small	  VA	  benefits	  significant	  enough	  to	  drive	  participants	  to	  adopt	  their	  preferred	  271	  
head	   posture	   in	  most	   visual	   tasks,	   or	   do	   other	   related	   factors	   such	   as	   response	   times	   or	  272	  
even	  comfort	  contribute?	  We	  have	  previously	  argued	  that	  the	  standard	  clinical	  protocol	  for	  273	  
measuring	  VA	  does	  not	  control	   for	  aspects	  of	  visual	  timing,	  and	  that	  this	  may	  explain	  why	  274	  
studies	   that	   do	   not	   employ	   a	   psychophysical	   protocol	   tend	   to	   find	   somewhat	   larger	   VA	  275	  
changes	   in	   response	   to	   nystagmus	   waveform	   modifications	   (since	   viewing	   times	   are	  276	  
naturally	  constrained	  by	  the	  implicit	  need	  to	  ‘move	  on’	  to	  the	  next	  test).6,7,33	  277	  
In	   accordance	   with	   previous	   studies,	   we	   have	   demonstrated	   a	   relationship	   between	  278	  
foveation	  duration	  and	  VA	  across	  participants.	  However,	  within	  an	  individual,	  there	  is	  only	  a	  279	  
small	  (yet	  significant)	  relationship	  between	  the	  change	  in	  any	  aspect	  of	  nystagmus	  and	  VA,	  280	  
which	   is	   also	   consistent	   with	   previous	   studies	   that	   have	   measured	   VA	   using	   a	   staircase	  281	  
protocol.11–13	   Therefore,	   VA	   in	   IN	   would	   appear	   not	   to	   be	   as	   sensitive	   to	   changes	   in	  282	  
nystagmus,	   presumably	   because	   VA	   is	   fundamentally	   limited,	   either	   due	   to	   amblyopia	   or	  283	  
undetected	  pathology.33	  This	  raises	  doubts	  about	  the	  usefulness	  of	  pursuing	  treatments	  that	  284	  
reduce	  nystagmus	   in	   the	  hope	  of	   improving	   vision,	   at	   least	  when	  VA	   is	   the	   sole	  outcome	  285	  
measure.	  Another	   consequence	   is	   that	   indirect	  measures	   of	  VA	   such	   as	   nystagmus	   acuity	  286	  
functions	   (which	   are	   based	   on	   between-­‐participant	   factors)	   are	   not	   valid	   for	   predicting	  287	  
individual	  changes	  in	  VA.	  At	  a	  more	  fundamental	  level,	  it	  is	  not	  clear	  why	  patients	  prefer	  to	  288	  
use	  their	  null	  zone,	  as	  the	  improvement	  in	  VA	  is	  very	  small,	  unless	  there	  are	  improvements	  289	  
in	  other	  aspects	  of	   ‘functional	   vision’	   such	  as	   response	   times.	  Therefore,	  we	  question	   the	  290	  
relevance	   of	   using	   time-­‐unrestricted	   VA	   as	   a	   sole	   outcome	   measure	   for	   nystagmus	  291	  
interventions,	   and	   argue	   that	   new	   methods	   of	   visual	   assessment	   are	   required	   to	   more	  292	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